Global Deferasirox Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Deferasirox Tablet Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.
Deferasirox Tablet report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Deferasirox Tablet market is projected to reach US$ 113.8 million in 2029, increasing from US$ 323 million in 2022, with the CAGR of -5.7% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The Exjade market is driven by the increasing prevalence of iron overload conditions, such as transfusional hemosiderosis in patients receiving regular blood transfusions. Exjade, a medication containing deferasirox, is used to manage iron overload by chelating excess iron and promoting its elimination from the body. The drug's efficacy in preventing iron-related complications has contributed to its growing adoption in the treatment of thalassemia and other transfusion-dependent disorders. Moreover, advancements in medical research and improved patient access have further propelled market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize dosing and monitoring strategies. Overcoming these challenges and expanding access to affordable and safe treatments will be crucial for the sustained growth of the Exjade market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Deferasirox Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Segment by Type
125mg
250mg
500mg
Hospital
Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Deferasirox Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Deferasirox Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Deferasirox Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Deferasirox Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Deferasirox Tablet introduction, etc. Deferasirox Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Deferasirox Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Deferasirox Tablet report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Deferasirox Tablet market is projected to reach US$ 113.8 million in 2029, increasing from US$ 323 million in 2022, with the CAGR of -5.7% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The Exjade market is driven by the increasing prevalence of iron overload conditions, such as transfusional hemosiderosis in patients receiving regular blood transfusions. Exjade, a medication containing deferasirox, is used to manage iron overload by chelating excess iron and promoting its elimination from the body. The drug's efficacy in preventing iron-related complications has contributed to its growing adoption in the treatment of thalassemia and other transfusion-dependent disorders. Moreover, advancements in medical research and improved patient access have further propelled market growth. However, challenges include the high cost of the medication, potential side effects, and the need for continued research to optimize dosing and monitoring strategies. Overcoming these challenges and expanding access to affordable and safe treatments will be crucial for the sustained growth of the Exjade market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Deferasirox Tablet market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Segment by Type
125mg
250mg
500mg
Segment by Application
Hospital
Pharmacy
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Deferasirox Tablet market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Deferasirox Tablet, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Deferasirox Tablet industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Deferasirox Tablet in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Deferasirox Tablet introduction, etc. Deferasirox Tablet Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Deferasirox Tablet market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices